Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Post Exposure Prophylaxis – NACO Guidelines Figure 1: Determination of Exposure Code (EC) Is the source material blood, bloody fluid or other potentially infectious material – OPIM (CSF, synovial, plural, pericardial and amniotic fluid, and pus) or an instrument contaminated with any of these substances? Yes No No PEP needed What is the type of exposure? Mucous membrane or skin with integrity compromised Percutaneous exposure Intact skin No PEP needed What is the volume of exposure? Small e.g., few drops, small duration EC 1 What is the severity of exposure? Large Less severe e.g., several drops, major blood splash, and/or duration of several minutes or more e.g., solid needle, superficial scratch EC 2 EC 2 More severe e.g., large bore hollow needle, deep puncture, visible blood on device, needle used in patient’s artery or vein EC 3 Post Exposure Prophylaxis – NACO Guidelines Figure 2: Determination of HIV Status Code (EC) What is the HIV status of the exposure source? HIV Negative HIV Positive Status unknown Source unknown No PEP needed Low titre exposure High titre exposure e.g. asymptomatic, high CD4 count e.g. advanced AIDS, primary HIV infection, high or increasing viral load, low CD4 count HIV SC 1 HIV SC 2 HIV SC Unknown Post Exposure Prophylaxis – NACO Guidelines Determining PEP recommendation EC 1 1 2 2 HIV SC PEP Recommendation 1 PEP may not be warranted. Exposure type does not pose a known risk for HIV transmission. Whether the risk for drug toxicity outweighs the benefit of PEP should be decided by the exposed HCW and treating clinician. 2 Consider basic regimen. Exposure type poses a negligible risk for HIV transmission. A high HIV titre in the source may justify consideration of PEP. Decision should be taken by the exposed HCW and treating clinician. 1 Recommended basic regimen. Most HIV exposures are in this category. No increased risk for HIV transmission has been observed but use of PEP is appropriate. 2 Recommended expanded regimen. There is an increased risk of HIV transmission. Unk 2/ no 3 wn Consider basic regimen. If the source (in case of an unknown source), and the setting where the exposure occurred suggests a possible risk for HIV exposure, PEP basic regimen can be considered. Post Exposure Prophylaxis – NACO Guidelines PEP must be initiated as soon as possible, preferably within 2 hours but not later than 72 hours. PEP drugs should be taken for 28 days. Basic Regimen • Zidovudine (AZT) – 600 mg in divided doses (300 mg twice a day or 200 mg thrice a day AND • Lamivudine (3TC) – 150 mg twice a day Expanded Regimen • Basic regimen AND • Indinavir (800 mg thrice a day) or Nelfinavir (750 mg thrice a day) HIV test and PEP regimen Baseline HIV test of the HCW should be done at the time of exposure and repeated at 6 weeks following exposure. If second test is also negative, HIV test to be repeated 12 weeks following exposure.